Please use symbol entry at top right of page to search

BP, Bunge to sell Brazil sugar and ethanol venture - report

SAO PAULO, Aug 9 (Reuters) - British oil major BP and U.S. commodities trader Bunge Ltd (BG) have put their Brazilian sugar and ethanol joint venture BP Bunge Bioenergia up for sale, newspaper Valor Economico reported on Tuesday.

Abu Dhabi's Mubadala and Brazilian energy company Raizen SA - a joint venture of Shell and Cosan SA (CSAN) - were among those interested to buy the company, said the report, citing sources familiar with the matter.

JPMorgan (JPM) will advise BP Bunge on the deal, Valor said, adding that the company's assets were valued at between 9 billion and 10 billion reais ($1.96 billion).

In a statement sent to Reuters, Bunge (BG) reiterated it was assessing options to exit its participation in the sugar and bioenergy joint venture, as previously disclosed by the company, but did not provide details on how that could happen.

"While we are pleased with how the business is performing, it is not core to our overall business strategy," Bunge (BG) said.

BP, Raizen and JPMorgan (JPM) declined to comment, while Mubadala did not immediately respond to a request for comment.

BP and Bunge's (BG) deal to create the 50-50 joint venture, managing 11 plants with a total capacity to crush 32 million tonnes of sugarcane per year, was first announced in 2019.

($1 = 5.1110 reais) (Reporting by Gabriel Araujo; Editing by Kirsten Donovan and Bernadette Baum)

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.